These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 10665264)

  • 21. Screening for cognitive deficits in Parkinson's disease with the Parkinson neuropsychometric dementia assessment (PANDA) instrument.
    Kalbe E; Calabrese P; Kohn N; Hilker R; Riedel O; Wittchen HU; Dodel R; Otto J; Ebersbach G; Kessler J
    Parkinsonism Relat Disord; 2008; 14(2):93-101. PubMed ID: 17707678
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Neuropsychological evaluation and psychological intervention on patients with Parkinson's disease in physical rehabilitation].
    Pierobon A; Giardini A; Callegari S; Farina C; Torlaschi V; Bernini S; Frazzitta G; Majani G
    G Ital Med Lav Ergon; 2013; 35(3):183-91. PubMed ID: 24734326
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metric properties of the mini-mental Parkinson and SCOPA-COG scales for rating cognitive deterioration in Parkinson's disease.
    Serrano-Dueñas M; Calero B; Serrano S; Serrano M; Coronel P
    Mov Disord; 2010 Nov; 25(15):2555-62. PubMed ID: 20824734
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The nonmotor symptoms of Parkinson's disease--an overview.
    Lim SY; Lang AE
    Mov Disord; 2010; 25 Suppl 1():S123-30. PubMed ID: 20187234
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Parkinson's disease dementia: definitions, guidelines, and research perspectives in diagnosis.
    Goetz CG; Emre M; Dubois B
    Ann Neurol; 2008 Dec; 64 Suppl 2():S81-92. PubMed ID: 19127578
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Decision making in Parkinson's disease: Analysis of behavioral and physiological patterns in the Iowa gambling task.
    Kobayakawa M; Koyama S; Mimura M; Kawamura M
    Mov Disord; 2008 Mar; 23(4):547-52. PubMed ID: 18069681
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The independent influence of apathy and depression on cognitive functioning in Parkinson's disease.
    Butterfield LC; Cimino CR; Oelke LE; Hauser RA; Sanchez-Ramos J
    Neuropsychology; 2010 Nov; 24(6):721-30. PubMed ID: 20853956
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cognitive and affective functioning in Parkinson's disease patients with lateralized motor signs.
    St Clair J; Borod JC; Sliwinski M; Cote LJ; Stern Y
    J Clin Exp Neuropsychol; 1998 Jun; 20(3):320-7. PubMed ID: 9845159
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Parkinson's disease--Part 3: Neuropsychiatric symptoms.
    Weintraub D; Comella CL; Horn S
    Am J Manag Care; 2008 Mar; 14(2 Suppl):S59-69. PubMed ID: 18402509
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical validation of Movement Disorder Society-recommended diagnostic criteria for Parkinson's disease with dementia.
    Barton B; Grabli D; Bernard B; Czernecki V; Goldman JG; Stebbins G; Dubois B; Goetz CG
    Mov Disord; 2012 Feb; 27(2):248-53. PubMed ID: 22162144
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A validation study of depressive syndromes in Parkinson's disease.
    Starkstein SE; Merello M; Jorge R; Brockman S; Bruce D; Petracca G; Robinson RG
    Mov Disord; 2008 Mar; 23(4):538-46. PubMed ID: 18074376
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relationship between cognitive dysfunction and behavioural symptoms in Nigerian patients with Parkinson's disease no dementia.
    Ojagbemi A
    J Parkinsons Dis; 2013 Jan; 3(3):293-300. PubMed ID: 23963316
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Drug treatments for the neuropsychiatric complications of Parkinson's disease.
    Connolly BS; Fox SH
    Expert Rev Neurother; 2012 Dec; 12(12):1439-49. PubMed ID: 23237351
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mechanism(s) of deep brain stimulation and insights into cognitive outcomes in Parkinson's disease.
    Naskar S; Sood SK; Goyal V; Dhara M
    Brain Res Rev; 2010 Oct; 65(1):1-13. PubMed ID: 20457181
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Cognitive and neuropsychiatric disorders in Parkinson's disease].
    Rodríguez-Constenla I; Cabo-López I; Bellas-Lamas P; Cebrián E
    Rev Neurol; 2010 Feb; 50 Suppl 2():S33-9. PubMed ID: 20205140
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Neuropsychiatric disorders in Parkinson's disease].
    Noé-Sebastián E; Irimia-Sieira P; Pomares-Arias E; Martínez-Vila E; Luquin-Piudo MR
    Rev Neurol; 2001 Apr 1-15; 32(7):676-81. PubMed ID: 11391498
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Personality in Parkinson's disease: Clinical, behavioural and cognitive correlates.
    Santangelo G; Piscopo F; Barone P; Vitale C
    J Neurol Sci; 2017 Mar; 374():17-25. PubMed ID: 28087060
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuropsychiatric disturbances in Parkinson's disease clusters in five groups with different prevalence of dementia.
    Bronnick K; Aarsland D; Larsen JP
    Acta Psychiatr Scand; 2005 Sep; 112(3):201-7. PubMed ID: 16095475
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Neuropsychological impairment in Parkinson's disease without dementia].
    Marañón D; Amayra I; Uterga JM; Gómez-Esteban JC
    Psicothema; 2011 Nov; 23(4):732-7. PubMed ID: 22047866
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nonmotor symptoms of Parkinson's disease.
    Zesiewicz TA; Sullivan KL; Hauser RA
    Expert Rev Neurother; 2006 Dec; 6(12):1811-22. PubMed ID: 17181428
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.